Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of Grazax in children with grass pollen-induced rhinoconjunctivitis
2006-003415-46Phase 3Completed
- Sponsor
- ALK-Abelló
- Start
- Sep 2006
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in allergic rhinoconjunctivitis (ARC) and allergic asthma comparing Grazax with Placebo (2 arms). Started Sep 2006; status: completed.
02
Drugs
phleum pratense allergen extract
03
Conditions
allergic rhinoconjunctivitis (ARC)allergic asthma
Beyond the preview
Go deeper on 2006-003415-46.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003415-46.